Stocks
Sarepta Therapeutics (SRPT) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -45.2% | -63.8% | -36.5% | 16.7% | -29.5% | 4.94% | ||
| Changes by years, y/y, % | +39pp | -19pp | +27pp | +53pp | -46pp | -18.9% | |||
Sarepta Therapeutics. EBITDA margin, %
Sarepta Therapeutics. EBITDA margin, changes, pp
Sarepta Therapeutics (SRPT) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | -49.5% | 27.8% | -42.1% | -56.9% | 49.0% | 4.94% | |
| Changes by years, y/y, % | -63pp | +20pp | -53pp | -85pp | +99pp | |||
| Changes by quarters, q/q, % | -78pp | +77pp | -70pp | -15pp | +106pp | |||
